Identification of DMP1 as Novel p53 Repressed Transcriptional Target.

The transcription factor DMP1 is a positive regulator of the tumor suppressor ARF, which in turn controls cell-cycle progression and/or apoptosis through p53. Given the role of DMP1 in the ARF-p53 pathway, we investigated whether the p53 transcription factor might regulate DMP1 expression. We found that endogenous human (h)DMP1 mRNA levels were significantly decreased upon induction of the temperature-sensitive p53Val135 in normal fibroblasts. Consistent with this observation, a p53 knockdown in MCF7 breast cancer cells resulted in increased hDMP1 mRNA and protein levels. At the molecular level, we found that p53 directly repressed the hDMP1 promoter activity by up to 90%. This repression was not mediated by p53 binding to the two putative p53-binding sites in the hDMP1 promoter. Instead, deletion analysis revealed a 300bp region containing an EGR1/SP1 binding site that is required for p53-dependent inhibition of hDMP1 promoter activity. Using Sp1-deficient SL2 insect cells, we confirmed that p53-mediated repression of hDMP1 is dependent on Sp1. Furthermore, chromatin immunoprecipitation demonstrated SP1 binding to the hDMP1 promoter. Together, our findings identify an Sp1-dependent, p53-mediated repression of DMP1.

Authors

Institutions

Publication Details

Journal
Open Access CRIS of the University of Bern
Published
2026-01-29
DOI
https://doi.org/10.48620/94638
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of DMP1 as Novel p53 Repressed Transcriptional Target.

Gustav Arvidsson, Deborah Krauer, Bruce E. Torbett, Inti Zlobec et al.
Open Access CRIS of the University of Bern
Cancer-related Molecular Pathways
article

Identification of DMP1 as Novel p53 Repressed Transcriptional Target.

Gustav Arvidsson, Deborah Krauer, Bruce E. Torbett, Inti Zlobec, Christian Britschgi, Mario P. Tschan, Jun Xu
article en

Abstract

The transcription factor DMP1 is a positive regulator of the tumor suppressor ARF, which in turn controls cell-cycle progression and/or apoptosis through p53. Given the role of DMP1 in the ARF-p53 pathway, we investigated whether the p53 transcription factor might regulate DMP1 expression. We found that endogenous human (h)DMP1 mRNA levels were significantly decreased upon induction of the temperature-sensitive p53Val135 in normal fibroblasts. Consistent with this observation, a p53 knockdown in MCF7 breast cancer cells resulted in increased hDMP1 mRNA and protein levels. At the molecular level, we found that p53 directly repressed the hDMP1 promoter activity by up to 90%. This repression was not mediated by p53 binding to the two putative p53-binding sites in the hDMP1 promoter. Instead, deletion analysis revealed a 300bp region containing an EGR1/SP1 binding site that is required for p53-dependent inhibition of hDMP1 promoter activity. Using Sp1-deficient SL2 insect cells, we confirmed that p53-mediated repression of hDMP1 is dependent on Sp1. Furthermore, chromatin immunoprecipitation demonstrated SP1 binding to the hDMP1 promoter. Together, our findings identify an Sp1-dependent, p53-mediated repression of DMP1.

Open Access CRIS of the University of Bern
Tumour Institute of Tuscany (IT)
Good health and well-being
Openalex Percentile: Top 54%
Cancer-related Molecular Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.